FB121 (ibalizumab biosimilar) / Microbio - LARVOL DELTA

Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection. (PubMed, Int J Mol Sci) - "Our case report about an HTE patient shows that IBA was efficacious in the rescue regimen, while also acting on the reservoir. LEN, adopted in a switch strategy which differed from that described in the literature, preserved efficacy and stable pressure on HIV-DNA."

Journal • Cardiovascular • Human Immunodeficiency Virus • Hypertension • Infectious Disease • CD4